Bioventix (BVXP) Competitors GBX 3,154.72 -95.28 (-2.93%) As of 01/17/2025 11:47 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider Trades BVXP vs. SLN, OXB, PRTC, HZD, VRP, FARN, AVCT, ARIX, 4BB, and CIRShould you be buying Bioventix stock or one of its competitors? The main competitors of Bioventix include Silence Therapeutics (SLN), Oxford Biomedica (OXB), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), Faron Pharmaceuticals Oy (FARN), Avacta Group (AVCT), Arix Bioscience (ARIX), 4basebio (4BB), and Circassia Group (CIR). These companies are all part of the "biotechnology" industry. Bioventix vs. Silence Therapeutics Oxford Biomedica PureTech Health Horizon Discovery Group plc (HZD.L) Verona Pharma plc (VRP.L) Faron Pharmaceuticals Oy Avacta Group Arix Bioscience 4basebio Circassia Group Silence Therapeutics (LON:SLN) and Bioventix (LON:BVXP) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, community ranking, risk, profitability, dividends, media sentiment and valuation. Do institutionals and insiders hold more shares of SLN or BVXP? 62.3% of Bioventix shares are held by institutional investors. 8.0% of Bioventix shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media favor SLN or BVXP? In the previous week, Bioventix had 1 more articles in the media than Silence Therapeutics. MarketBeat recorded 1 mentions for Bioventix and 0 mentions for Silence Therapeutics. Bioventix's average media sentiment score of 1.16 beat Silence Therapeutics' score of 0.00 indicating that Bioventix is being referred to more favorably in the news media. Company Overall Sentiment Silence Therapeutics Neutral Bioventix Positive Which has preferable earnings & valuation, SLN or BVXP? Bioventix has higher revenue and earnings than Silence Therapeutics. Silence Therapeutics is trading at a lower price-to-earnings ratio than Bioventix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSilence Therapeutics£11.35M0.00N/A-£48.60N/ABioventix£13.60M12.11£8.67M£1.631,935.41 Is SLN or BVXP more profitable? Bioventix has a net margin of 63.73% compared to Silence Therapeutics' net margin of 0.00%. Bioventix's return on equity of 79.14% beat Silence Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Silence TherapeuticsN/A N/A N/A Bioventix 63.73%79.14%54.07% Does the MarketBeat Community prefer SLN or BVXP? Silence Therapeutics received 111 more outperform votes than Bioventix when rated by MarketBeat users. Likewise, 68.81% of users gave Silence Therapeutics an outperform vote while only 52.87% of users gave Bioventix an outperform vote. CompanyUnderperformOutperformSilence TherapeuticsOutperform Votes20368.81% Underperform Votes9231.19% BioventixOutperform Votes9252.87% Underperform Votes8247.13% SummaryBioventix beats Silence Therapeutics on 10 of the 12 factors compared between the two stocks. Get Bioventix News Delivered to You Automatically Sign up to receive the latest news and ratings for BVXP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BVXP vs. The Competition Export to ExcelMetricBioventixBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£164.68M£176.09M£5.22B£2.06BDividend Yield3.95%3.64%5.13%5.16%P/E Ratio1,935.41133.2089.721,943.78Price / Sales12.1118,796.851,251.21427,090.66Price / Cash30.8913.0143.8229.43Price / Book14.419.535.323.10Net Income£8.67M-£20.89M£122.69M£158.20M7 Day Performance-4.26%-0.62%-0.16%3.25%1 Month Performance-4.40%2.41%3.75%2.64%1 Year Performance-26.63%136.98%27.41%174.99% Bioventix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BVXPBioventixN/AGBX 3,154.73-2.9%N/A-28.3%£164.68M£13.60M1,935.4112News CoveragePositive NewsSLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumeOXBOxford Biomedica0.6154 of 5 starsGBX 407-0.7%GBX 433.33+6.5%+120.4%£428.82M£97.28M-282.64891PRTCPureTech Health1.5272 of 5 starsGBX 142.80+2.4%GBX 455+218.6%-22.9%£341.89M£3.33M-620.87300Gap DownHZDHorizon Discovery Group plc (HZD.L)N/AN/AN/AN/A£302.98M£54.63M-33.55416VRPVerona Pharma plc (VRP.L)N/AN/AN/AN/A£228MN/A-1.6822News CoverageGap UpFARNFaron Pharmaceuticals OyN/AGBX 198-1.0%N/A-26.9%£207.15M£-725,000.00-618.7534Gap UpAVCTAvacta GroupN/AGBX 52.78+1.5%N/A-49.5%£189.11M£22.62M-586.44120News CoverageARIXArix BioscienceN/AN/AN/AN/A£183.73M£14.16M1,290.9194BB4basebioN/AGBX 1,207-3.4%N/A+86.4%£154.62M£311,000.00-1,547.44101Gap DownCIRCircassia GroupN/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap Down Related Companies and Tools Related Companies Silence Therapeutics Competitors Oxford Biomedica Competitors PureTech Health Competitors Horizon Discovery Group plc (HZD.L) Competitors Verona Pharma plc (VRP.L) Competitors Faron Pharmaceuticals Oy Competitors Avacta Group Competitors Arix Bioscience Competitors 4basebio Competitors Circassia Group Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:BVXP) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioventix PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioventix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BVXP Stock Alerts